FarrokhDehdashtiMD

Nuclear Medicine • Saint Louis, MO

Professor, Radiology, Washington University School of Medicine

Join to view full profile

Dr. Dehdashti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dehdashti's full profile

Already have an account?

Office
510 S Kingshighway Blvd
Dept
Saint Louis, MO 63110
Phone+1 314-362-7200

Fax+1 314-747-4189

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Nuclear Medicine, 1988 - 1990
Medical College of Wisconsin Affiliated HospitalsResidency, Nuclear Medicine, 1986 - 1988
Shiraz University of Medical SciencesClass of 1977
Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic

Certifications & Licensure

MO State Medical License 1988 - 2026
WI State Medical License 1988 - 1989
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Positron Emission Tomography in Prostate Cancer Start of enrollment: 2003 Jul 01
Completed
Not Applicable
Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer Start of enrollment: 2009 Jul 29
Terminated
Phase 2
Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP) Start of enrollment: 2007 Jan 01
Completed
Phase 1
Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 Start of enrollment: 2009 Jan 01
Completed
Phase 1
FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer Start of enrollment: 2010 Apr 01
Active, not recruiting
Not Applicable
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors Start of enrollment: 2012 Jun 01
Terminated
Early Phase 1
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2013 May 31
Completed
Phase 1
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography Start of enrollment: 2014 Feb 01
Completed
Early Phase 1
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery Start of enrollment: 2014 Jun 01
Terminated
Phase 1
64Cu-LLP2A for Imaging Multiple Myeloma Start of enrollment: 2018 Nov 20
TERMINATED
EARLY_PHASE1
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy Start of enrollment: 2019 Jan 02
RECRUITING
PHASE1
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer Start of enrollment: 2020 Feb 07
TERMINATED
PHASE1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

4 citations
F-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-Expert Panel Narrative Review.
Matthew F Covington, Sophia R O'Brien, Courtney Lawhn-Heath, Austin R Pantel, Gary A Ulaner
AJR. American Journal of Roentgenology. 2024-10-01
1 citations
Molecular Imaging of Steroid Receptors in Breast Cancer.
Quinton J Keigley, Quinton J Keigley, Quinton J Keigley, Amy M Fowler, Sophia R O'Brien
Cancer Journal. 2024-05-16
11 citations
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[F]Fluoro-17β-Estradiol PET.
David Mankoff, Soňa Balogová, Lisa Dunnwald, Farrokh Dehdashti, Erik DeVries
Journal of Nuclear Medicine. 2024-02-01

Press Mentions

Dehdashti Named Siegel Professor of RadiologyJuly 25th, 2019

Grant Support

FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancerWASHINGTON UNIVERSITY2022–2027
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted TherapyWASHINGTON UNIVERSITY2019–2025

FarrokhDehdashtiMD

Dr. Dehdashti is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.